Clinical trials

  • ACALABRUTINIB for Chronic lymphocytic leukaemia | Moderate to severe cardiac impairment
  • Hydroxychloroquine sulfate for Primary Sjögren's syndrome
  • EYE103 for Diabetic macular edema
  • Cabergoline for Non-functioning pituitary adenoma
  • Alendronic acid (Alendronate) for Osteoporosis
  • ALPHA-1-PROTEINASE INHIBITOR (HUMAN) for Pulmonary emphysema due to alpha-1 antitrypsin deficiency
  • TENECTEPLASE for Acute ischemic stroke
  • Everolimus for Age-related bone loss
  • RIVAROXABAN for Lower limb trauma
  • RUSFERTIDE for Polycythemia vera
  • iptacopan for Paroxysmal nocturnal haemoglobinuria (PNH)
  • pembrolizumab for Cutaneous melanoma (completely resected, Stage IIB–III)